RE:U.S. Where is the updated IP, oncology still preclinical, why not feed/encourage folks like liver lady to write frequent articles explaining the company's prospects on well followed seeking alpha, why not preparing a convincing presentation post it on drbeen with over 200 k followers on YouTube, how the heck can US and the rest of the world would get it when they only attend few conferences with limited audience?
They are constantly few steps behind with no efforts to raise the market awareness of their operations.
Yes great to achieve milestones but limited exposure thus no reaction.
Bucknelly21 wrote: Maybe the u.s. just doesn't like Thtx. This is pathetic